165 related articles for article (PubMed ID: 33982510)
1. [Application of add-on-design in post-marketing evaluation of traditional Chinese medicine].
Yang ZQ; Tang HM; DU YP; Tang YQ; Yuan TH; Wang ZF; Xie YM
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1994-1998. PubMed ID: 33982510
[TBL] [Abstract][Full Text] [Related]
2. [Key points of post-marketing evaluation of classic traditional Chinese medicine prescriptions based on combination of disease and syndrome].
Wang XL; Zhu MJ; Wang JR; Li B; Yu R; Peng GC; Zhao QF; Wang YX
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):2004-2009. PubMed ID: 33982512
[TBL] [Abstract][Full Text] [Related]
3. [Guidelines for post-marketing research on clinical effectiveness of Chinese patent medicines].
Wang ZF; Xie YM; Tang JY; Zhang JH; Sun X; Yang ZQ
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):842-848. PubMed ID: 38621888
[TBL] [Abstract][Full Text] [Related]
4. [Research and development strategy of new traditional Chinese medicine drugs for syndromes based on human use experience].
Yang ZQ; He XL; Liu DH; Tang YQ; Tang HM; Ling Y; DU YP
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):849-852. PubMed ID: 38621889
[TBL] [Abstract][Full Text] [Related]
5. [Suggestions on design of evidence-based traditional Chinese medicine clinical study for new public health emergencies].
Wang LX; Xie YM
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2291-2295. PubMed ID: 32495582
[TBL] [Abstract][Full Text] [Related]
6. [Exploration and practice of post-marketing survival benefit evaluation of Chinese patent medicine for cancer].
Xu BW; Wu JY; Li J; Zhang Y; Cao LC; Zhang XX; Gao RK
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1980-1987. PubMed ID: 33982508
[TBL] [Abstract][Full Text] [Related]
7. [Technical specification for re-evaluation of post-marketing clinical effectiveness of traditional Chinese medicine (first draft)].
Zhao Y; Yang YY; Wang YX; Yang HM; Wu SX
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3211-3215. PubMed ID: 30200720
[TBL] [Abstract][Full Text] [Related]
8. [Conception and practice of "three dimensions and four stages" clinical orientation method for post-marketing evaluation of traditional Chinese medicine].
Wang ZF; Xie YM
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1967-1972. PubMed ID: 33982506
[TBL] [Abstract][Full Text] [Related]
9. [Thoughts on post-marketing evaluation of classical Chinese patent medicines based on clinical value].
Song Z; Wang ZF; Wu Y; Xie YM; Yang YF; Xu Y
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1988-1993. PubMed ID: 33982509
[TBL] [Abstract][Full Text] [Related]
10. [Application of objective performance criteria in post-marketing evaluation schemes of traditional Chinese medicine].
Zhang C; Yu MK; Tang JP; Huo YQ; Fei YT; Wang ZF; Xu Q; Xie YM
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1999-2003. PubMed ID: 33982511
[TBL] [Abstract][Full Text] [Related]
11. [Consensus on collaborative ethical review of multi-center clinical trials of new drugs of traditional Chinese medicine (version 1.0)].
Zou C; Ding H; Gao R; Hu SY; Liu JZ; Li B; Li XH; Pan DJ; Tang JY; Tong XY; Wang JY; Yuan WA; Zhang X; Zhang M; Zhao YL; Yang ZQ
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1696-1700. PubMed ID: 33982471
[TBL] [Abstract][Full Text] [Related]
12. [Theoretical thinking on guiding research and development of new drugs of traditional Chinese medicine].
Yang ZQ; Tang HM; Tang YQ; DU YP; Yuan WA; Li B; Zou C; Tang JY; Gao R; Hu SY; Zhang L
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1686-1690. PubMed ID: 33982469
[TBL] [Abstract][Full Text] [Related]
13. [Advantages and disadvantages of production quality of Fufang Danshen Prescription based on high-quality Chinese patent medicine evaluation criteria].
Zhao AY; Liu YP; Chen S; Guo C; Liu YZ; Wang ZG; Liu Y; Liu A
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4814-4822. PubMed ID: 36164888
[TBL] [Abstract][Full Text] [Related]
14. [Thinking and practice of key links in design of clinical trial scheme for treatment of influenza with traditional Chinese medicine].
Li ZX; Zhao GZ; Guo YH; Li B; Liu QQ
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1706-1710. PubMed ID: 33982473
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation and analysis of high-quality products of Liuwei Dihuang Pills].
Liu Y; Zhao AY; Ni FY; Yu HC; Cheng JT; DI JP; Liu YZ; Wang ZG; Liu A
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1194-1201. PubMed ID: 32237465
[TBL] [Abstract][Full Text] [Related]
16. [Post-marketing reevaluation for potential quality risk and quality control in clinical application of traditional Chinese medicines].
Li HJ; He LY; Liu BY
Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(12):2461-3. PubMed ID: 26591543
[TBL] [Abstract][Full Text] [Related]
17. [Development of clinical trial of new drugs of traditional Chinese medicines].
Yang ZQ; Tang YQ; DU YP; Tang HM; Zhang L; Gao R; Hu SY; Tang JY; Yuan WA
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1691-1695. PubMed ID: 33982470
[TBL] [Abstract][Full Text] [Related]
18. [Post-marketing effectiveness evaluation of traditional Chinese medicine in paradigm based on "proving efficacy, conforming standard, and exploring mechanism":a case study of Danhong Injection].
Yu YN; Liu J; Wang Z
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):279-284. PubMed ID: 36725281
[TBL] [Abstract][Full Text] [Related]
19. [Application of real world study and human use experience in research and development of new traditional Chinese medicine drugs].
Yang ZQ; Tang HM; Tang YQ; DU YP; Gao R; Hu SY; Yuan WA; Zou C; Ding H; Zhao YL
Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(22):5987-5991. PubMed ID: 34951190
[TBL] [Abstract][Full Text] [Related]
20. [Study on precise mechanism of Chinese patent medicine from perspective of activating data].
Wang LX; Xie YM
Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(14):3331-3335. PubMed ID: 32726047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
